One of the most common lung disorders in adults is chronic obstructive pulmonary disease (COPD), a term used to include chronic bronchitis and emphysema . Obstruction due to airway inflammation and excess mucus occurs in the airways of the lung (called bronchi and bronchioles ), leading to decreased air flow. This ultimately results in decreased amounts of oxygen delivered to the body's tissues. In emphysema, there is also destruction of the alveoli (tiny sacs where oxygen and carbon dioxide exchange takes place). Emphysema and chronic bronchitis may both be present in an individual at the same time. COPD is one of the leading causes of death in developed nations and affects both men and women. Smoking is the cause of COPD in most cases and accounts for 80% to 90% of COPD-related deaths. The November 26, 2008, issue of JAMA includes an article about COPD.
Grahic Jump Location
Shortness of breath
Cough
Sputum production
Wheezing
Decreased blood oxygen levels and increased carbon dioxide levels
Exercise intolerance
Measurement of breathing volumes, called spirometry , is the most important test for COPD. A bronchodilator (a medication that helps to relax airway muscles and open the bronchioles) may be given to see if a person's spirometric measurements improve. Arterial blood gas sampling (blood taken from an artery, not a vein) shows the levels of oxygen and carbon dioxide in the bloodstream. Pulse oximetry , a noninvasive tool used routinely in intensive care units and during any type of anesthesia, measures the oxygen saturation of hemoglobin, which is a reflection of the amount of oxygen in the bloodstream. Chest x-ray is used to determine the amount of lung damage done by COPD and can also indicate the presence of pneumonia (lung infection) or other types of lung disease processes.
Stop smoking! This is the most important step in treating COPD (or any other lung disease).
Medications including bronchodilators (to widen the airways), inhaled steroids (to reduce airway inflammation), and antibiotics (used to treat infection if it is present) may be prescribed. Often, several medications are used in combination to treat COPD.
Some individuals may require oxygen therapy at night, during activity, or, in some cases, at all times.
Pulmonary rehabilitation, including exercise, may increase functional status (ability to perform daily activities).
Vaccines for prevention of influenza and pneumococcal diseases are recommended for persons who have COPD.
American Lung Associationhttp://www.lungusa.org
National Heart, Lung, and Blood Institutehttp://www.nhlbi.nih.gov
American Thoracic Societyhttp://www.thoracic.org
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on evaluating lung function was published in the May 16, 2007, issue; one on adult asthma was published in the July 21, 2004, issue; and one on smoking cessation was published in the December 12, 2007, issue.
Sources: National Heart, Lung, and Blood Institute; American Lung Association
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
TOPIC: LUNG DISEASES
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature Consider an RCT of corticosteroids in patients with an acute exacerbation of chronic obstructive...
Users' Guides to the Medical Literature For example, in a study examining HRQL in patients with chronic airflow limitation who were...
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.